Electrical and Ultrasonic Bone Growth Stimulators – Commercial and Individual Exchange Medical Policyopen_in_new
Defines UnitedHealthcare Commercial and Individual Exchange coverage criteria for invasive and non‑invasive electrical bone growth stimulators and low‑intensity pulsed ultrasonic bone growth stimulators, including specific clinical criteria for spinal fusion adjunctive use and for treatment of long-bone nonunion, and lists applicable procedure and HCPCS codes and documentation requirements.
Title changed (previously 'Electrical and Ultrasound Bone Growth Stimulators').
Added language that use of an invasive or non-invasive electrical bone growth stimulator is unproven and not medically necessary for treatment of all other indications (including stress fractures).
Revised coverage criteria for Ultrasonic Bone Growth Stimulators: replaced 'less than 6 months have passed since the date of most recent surgical operation' with 'less than 6 months have passed since the date of most recent surgical procedure'.
Added documentation items to Medical Records Documentation Used for Reviews for Electrical Bone Growth Stimulators (condition requiring procedure; imaging evidence of skeletal maturity and spondylolisthesis grade if present; physician's treatment plan).
Removed reference link to Medicare Advantage Medical Policy titled 'Electrical Stimulators Coverage Rationale Electrical Bone Growth Stimulators'.
Updated Description of Services, Clinical Evidence, and References sections to reflect current information.
Archived previous policy version 2026T0561W.